CNMD CONMED Corp
Price (delayed)
$61.13
Market cap
$1.89B
P/E Ratio
14.25
Dividend/share
$0.8
EPS
$4.29
Enterprise value
$2.77B
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties,
Highlights
The net income has soared by 105% year-on-year
CNMD's EPS has soared by 104% YoY
CNMD's quick ratio is up by 9% YoY but it is down by 2.1% QoQ
Key stats
What are the main financial stats of CNMD
Market
Valuations
Earnings
Shares outstanding
30.91M
Market cap
$1.89B
Enterprise value
$2.77B
Price to earnings (P/E)
14.25
Price to book (P/B)
1.96
Price to sales (P/S)
1.44
EV/EBIT
13.83
EV/EBITDA
12.77
EV/Sales
2.12
Revenue
$1.31B
Gross profit
$733.03M
Operating income
$200.33M
Net income
$132.42M
EBIT
$200.33M
EBITDA
$216.93M
Free cash flow
$153.88M
Per share
Balance sheet
Liquidity
EPS
$4.29
EPS diluted
$4.25
Free cash flow per share
$4.98
Book value per share
$31.16
Revenue per share
$42.31
TBVPS
$28.59
Total assets
$2.31B
Total liabilities
$1.34B
Debt
$905.78M
Equity
$962.68M
Working capital
$361.88M
Debt to equity
0.94
Current ratio
2.3
Quick ratio
0.94
Net debt/EBITDA
4.06
Margins
Efficiency
Dividend
EBITDA margin
16.6%
Gross margin
56.1%
Net margin
10.1%
Operating margin
15.3%
Return on assets
5.7%
Return on equity
14.6%
Return on invested capital
13.3%
Return on capital employed
9.9%
Return on sales
15.3%
Dividend yield
1.31%
DPS
$0.8
Payout ratio
18.6%
CNMD stock price
How has the CONMED stock price performed over time
Intraday
-0.29%
1 week
-3.2%
1 month
-13.84%
1 year
-24.98%
YTD
-10.68%
QTD
-10.68%
Financial performance
How have CONMED's revenue and profit performed over time
Revenue
$1.31B
Gross profit
$733.03M
Operating income
$200.33M
Net income
$132.42M
Gross margin
56.1%
Net margin
10.1%
The net income has soared by 105% year-on-year
The company's net margin has surged by 94% YoY
The operating income has soared by 66% year-on-year
The operating margin has surged by 58% year-on-year
Growth
What is CONMED's growth rate over time
Valuation
What is CONMED stock price valuation
P/E
14.25
P/B
1.96
P/S
1.44
EV/EBIT
13.83
EV/EBITDA
12.77
EV/Sales
2.12
CNMD's EPS has soared by 104% YoY
The stock's price to earnings (P/E) is 97% less than its 5-year quarterly average of 469.0 and 32% less than its last 4 quarters average of 21.0
The stock's price to book (P/B) is 50% less than its 5-year quarterly average of 3.9 and 22% less than its last 4 quarters average of 2.5
CNMD's equity is up by 15% YoY and by 3.2% from the previous quarter
CNMD's P/S is 50% less than its 5-year quarterly average of 2.9 and 15% less than its last 4 quarters average of 1.7
CNMD's revenue is up by 5% year-on-year
Efficiency
How efficient is CONMED business performance
CNMD's return on assets has surged by 104% year-on-year
The ROE has soared by 78% YoY but it has contracted by 2.7% from the previous quarter
CNMD's return on invested capital has surged by 64% year-on-year
CNMD's ROS has soared by 58% YoY
Dividends
What is CNMD's dividend history
DPS
$0.8
Dividend yield
1.31%
Payout ratio
18.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did CONMED financials performed over time
CNMD's total assets is 72% greater than its total liabilities
The current ratio has grown by 16% YoY
CNMD's quick ratio is up by 9% YoY but it is down by 2.1% QoQ
The company's debt is 6% lower than its equity
The company's debt to equity fell by 20% YoY and by 7% QoQ
CNMD's equity is up by 15% YoY and by 3.2% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.